Cargando…
Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
A 60- to 65-year-old female on prior statin therapy was initiated on palbociclib and fulvestrant for the treatment of metastatic, hormone-receptor positive breast cancer. She subsequently developed sudden progressive muscle weakness that progressed to death within weeks. The patient noticed progress...
Autores principales: | Nelson, Kellie Lynn, Stenehjem, David, Driscoll, Meghan, Gilcrease, Glynn Weldon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511828/ https://www.ncbi.nlm.nih.gov/pubmed/28770167 http://dx.doi.org/10.3389/fonc.2017.00150 |
Ejemplares similares
-
Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2022) -
Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2023) -
Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report
por: Nersesjan, Vardan, et al.
Publicado: (2019) -
Pazopanib and Statin-Induced Rhabdomyolysis
por: Logue, Jennifer M., et al.
Publicado: (2017) -
Image of Statin-Induced Rhabdomyolysis
por: Kim, Min Chul, et al.
Publicado: (2020)